| scholarly article | Q13442814 |
| P2093 | author name string | Andrew D Badley | |
| James M Steckelberg | |||
| Mark S Rouse | |||
| Joel G R Weaver | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| P304 | page(s) | 1185-1191 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis | |
| P478 | volume | 18 |
| Q36681505 | AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality |
| Q36622618 | Apoptosis and caspases regulate death and inflammation in sepsis |
| Q38998292 | Apoptosis-induced lymphopenia in sepsis and other severe injuries |
| Q35111879 | Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells |
| Q42266564 | Different changes in mitochondrial apoptotic pathway in lymphocytes and granulocytes in cirrhotic patients with sepsis. |
| Q44814590 | Dopamine affects cellular immune functions during polymicrobial sepsis |
| Q37618990 | Endogenous IL-10 regulates sepsis-induced thymic apoptosis and improves survival in septic IL-10 null mice |
| Q50944239 | Erythropoietin prevents lymphoid apoptosis but has no effect on survival in experimental sepsis. |
| Q53565927 | Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survival. |
| Q42056965 | G-protein-coupled receptor kinase-5 mediates inflammation but does not regulate cellular infiltration or bacterial load in a polymicrobial sepsis model in mice. |
| Q37066766 | HIV protease inhibitors impact on apoptosis. |
| Q36667270 | HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice |
| Q47692695 | High-mobility group box 1 protein is involved in the protective effect of Saquinavir on ventilation-induced lung injury in mice |
| Q37780755 | ICU-acquired immunosuppression and the risk for secondary fungal infections. |
| Q34039180 | IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. |
| Q47565961 | Immune aspects of sepsis and hope for new therapeutics |
| Q38836832 | Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression |
| Q36068283 | In vitro and in vivo effects of HIV protease inhibitors on apoptosis |
| Q43066948 | Lysozyme activates Enterococcus faecium to induce necrotic cell death in macrophages |
| Q34585151 | Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony |
| Q42860266 | Nelfinavir monotherapy increases naïve T-cell numbers in HIV-negative healthy young adults |
| Q37227034 | Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis |
| Q43637055 | Optimized administration regimen of lopinavir for a myocardial ischaemia reperfusion study in Sprague-Dawley rats |
| Q37038249 | Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome |
| Q57160595 | Precision Immunotherapy for Sepsis |
| Q35147518 | Prevention of lymphocyte apoptosis in septic mice with cancer increases mortality |
| Q35855605 | Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice |
| Q34662282 | Revisiting caspases in sepsis |
| Q41114371 | Role of Programmed Cell Death in the Immunopathogenesis of Sepsis |
| Q34177314 | Role of circulating lymphocytes in patients with sepsis |
| Q37144425 | Severe bacteremia results in a loss of hepatic bacterial clearance |
| Q38357779 | The HIV protease inhibitor saquinavir inhibits HMGB1 driven inflammation by targeting the interaction of cathepsin V with TLR4/MyD88 |
| Q36789484 | The apoptotic pathway as a therapeutic target in sepsis |
| Q79879617 | Ulinastatin alone does not reduce caspase 3-mediated apoptosis in protease-positive Aeromonas hydrophilia-induced sepsis |
Search more.